Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein O-fucosyltransferase 2 (POFUT2) is an endoplasmic reticulum-localized enzyme in the glycosyltransferase family that catalyzes the addition of O-linked fucose to specific serine or threonine residues within thrombospondin type 1 repeats (TSRs) of more than 40 human proteins[1][2][3]. POFUT2 is highly selective for properly folded TSR domains, relying on recognition of a distinct three-dimensional fold rather than sequence motifs[1][2]. This modification is critical for proper folding, function, and quality control of TSR-containing proteins in the secretory pathway, making POFUT2 essential for the stability and trafficking of these substrates[3][4]. In pathogens like Plasmodium falciparum, loss of POFUT2 disrupts trafficking and function of key surface proteins, impairing infectiousness[4]. While not currently a direct therapeutic target, impairment of its enzymatic activity could affect processes involving TSR-containing proteins.
Not applicable (no known drugs targeting POFUT2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein O-fucosyltransferase 2 (POFUT2).